CompletedPhase 4NCT00349258

The Use of GnRH Agonist Trigger in the Prevention of OHSS

Studying Ovarian hyperstimulation syndrome

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University of Connecticut
Principal Investigator: Claudio Benadiva, MD
UConn Health
Intervention: Leuprolide acetate(drug)
Enrollment: 66 target
Eligibility: 20-39 years · FEMALE
Timeline: 2004 – 2006

Study locations (1)

Center for Advanced Reproductive Services, UCHC, Farmington, Connecticut, United States

Collaborators

Organon

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00349258 on ClinicalTrials.gov

Other trials for Ovarian hyperstimulation syndrome

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE2NCT07043322
Clinical Study to Evaluate Efficacy of Cabergoline to Coasting in Reducing the Incidence of Ovarian Hyperstimulation Syndrome
Tanta University

See all trials for Ovarian hyperstimulation syndrome →

← Back to all trials